Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mansour, 2017, Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma, Front. Immunol., 8, 954, 10.3389/fimmu.2017.00954
Giuliani, 2006, Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition, Blood, 108, 3992, 10.1182/blood-2006-05-026112
Terpos, 2018, Pathogenesis of bone disease in multiple myeloma: From bench to bedside, Blood Cancer J., 8, 7, 10.1038/s41408-017-0037-4
Fisher, 1999, Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro, Proc. Natl. Acad. Sci. USA, 96, 133, 10.1073/pnas.96.1.133
Lee, 2017, Bisphosphonate guidelines for treatment and prevention of myeloma bone disease, Intern. Med. J., 47, 938, 10.1111/imj.13502
Corre, 2007, Bone marrow mesenchymal stem cells are abnormal in multiple myeloma, Leukemia, 21, 1079, 10.1038/sj.leu.2404621
Arnulf, 2007, Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma, Leukemia, 21, 158, 10.1038/sj.leu.2404466
Garderet, 2007, Mesenchymal stem cell abnormalities in patients with multiple myeloma, Leuk. Lymphoma, 48, 2032, 10.1080/10428190701593644
Bafico, 2001, Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow, Nat. Cell Biol., 3, 683, 10.1038/35083081
Xu, 2018, Mesenchymal stem cells in multiple myeloma: A therapeutical tool or target?, Leukemia, 32, 1500, 10.1038/s41375-018-0061-9
Gimble, 2007, Adipose-derived stem cells for regenerative medicine, Circ. Res., 100, 1249, 10.1161/01.RES.0000265074.83288.09
Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905
Mizuno, 2012, Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine, Stem Cells, 30, 804, 10.1002/stem.1076
Bourin, 2013, Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT), Cytotherapy, 15, 641, 10.1016/j.jcyt.2013.02.006
Secunda, 2015, Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: A comparative study, Cytotechnology, 67, 793, 10.1007/s10616-014-9718-z
Zhu, M., Heydarkhan-Hagvall, S., Hedrick, M., Benhaim, P., and Zuk, P. (2013). Manual isolation of adipose-derived stem cells from human lipoaspirates. J. Vis. Exp., e50585.
Gorwood, 2019, Impact of HIV/SIV infection and viral proteins on adipose tissue fibrosis and adipogenesis, AIDS, 33, 953, 10.1097/QAD.0000000000002168
Lagathu, 2007, Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages, Antivir. Ther., 12, 489, 10.1177/135965350701200407
Cotter, 2011, HIV type 1 alters mesenchymal stem cell differentiation potential and cell phenotype ex vivo, AIDS Res. Hum. Retroviruses, 27, 187, 10.1089/aid.2010.0114
Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. USA, 92, 9363, 10.1073/pnas.92.20.9363
Caron, 2008, Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues, Antivir. Ther., 13, 27, 10.1177/135965350801300103
Silbermann, 2013, Myeloma bone disease: Pathophysiology and management, J. Bone Oncol., 2, 59, 10.1016/j.jbo.2013.04.001
Li, 2007, Elevated tumor necrosis factor-alpha suppresses TAZ expression and impairs osteogenic potential of Flk-1+ mesenchymal stem cells in patients with multiple myeloma, Stem Cells Dev., 16, 921, 10.1089/scd.2007.0074
Tian, 2003, The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma, N. Engl. J. Med., 349, 2483, 10.1056/NEJMoa030847
Gao, 2017, CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential, Stem Cells, 35, 1799, 10.1002/stem.2635
Baglio, 2015, Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species, Stem Cell Res. Ther., 6, 127, 10.1186/s13287-015-0116-z
Gao, 2011, MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow, J. Cell Biochem., 112, 1844, 10.1002/jcb.23106
Aval, 2018, The effect of ketorolac and triamcinolone acetonide on adipogenic and hepatogenic differentiation through miRNAs 16/15/195: Possible clinical application in regenerative medicine, Biomed. Pharmacother., 97, 675, 10.1016/j.biopha.2017.10.126
Fakhry, 2013, Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts, World J. Stem Cells, 5, 136, 10.4252/wjsc.v5.i4.136
Zhang, 2015, Exosomes in cancer: Small particle, big player, J. Hematol. Oncol., 8, 83, 10.1186/s13045-015-0181-x
Kumar, 2018, Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion, Leukemia, 32, 575, 10.1038/leu.2017.259
Pinzone, 2009, The role of Dickkopf-1 in bone development, homeostasis, and disease, Blood, 113, 517, 10.1182/blood-2008-03-145169
Gustafson, 2010, Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: A link with osteogenesis, Diabetologia, 53, 536, 10.1007/s00125-009-1615-1
Veld, 2016, Abdominal adipose tissue in MGUS and multiple myeloma, Skeletal. Radiol., 45, 1277, 10.1007/s00256-016-2425-4
Chong, M., Yin, T., Chen, R., Xiang, H., Yuan, L., Ding, Y., Pan, C.C., Tang, Z., Alexander, P.B., and Li, Q.J. (2018). CD36 initiates the secretory phenotype during the establishment of cellular senescence. EMBO Rep., 19.
Oshima, 2005, Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2, Blood, 106, 3160, 10.1182/blood-2004-12-4940
Kwack, 2012, Dickkopf 1 promotes regression of hair follicles, J. Invest. Dermatol., 132, 1554, 10.1038/jid.2012.24
Lyros, 2014, Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis, Am. J. Physiol. Gastrointest. Liver Physiol., 306, G557, 10.1152/ajpgi.00153.2013
Rani, 2018, Effect of Dickkopf1 on the senescence of melanocytes: In vitro study, Arch. Dermatol. Res., 310, 343, 10.1007/s00403-018-1820-1